What audiology practices and hearing aid clinics actually sell for in today's lower middle market — from $300K to $1M+ EBITDA.
Hearing centers typically trade at 3.5x–6x EBITDA in the lower middle market. Valuations are driven by patient base depth, associate audiologist staffing, recurring revenue mix, and Medicare compliance. Roll-up platforms and ENT groups are active acquirers, supporting strong multiples for well-documented practices with reduced owner dependency.
| Business Tier | EBITDA Range | Multiple Range | Notes |
|---|---|---|---|
| Entry-Level / Single Provider | $300K–$450K | 3.5x–4.0x | Owner-operated, no associate audiologist, limited documentation, moderate patient retention risk, and minimal revenue diversification beyond hearing aid sales. |
| Established Independent | $450K–$650K | 4.0x–4.75x | Multi-year patient database, some staff depth, clean Medicare billing history, and consistent hearing aid unit volume with moderate owner dependency. |
| Growth-Stage Clinic | $650K–$900K | 4.75x–5.5x | Associate audiologist on staff, diversified revenue across testing and devices, favorable manufacturer agreements, and strong patient retention metrics. |
| Platform-Ready Practice | $900K–$1.5M+ | 5.5x–6.0x+ | Multiple providers, high reappointment rates, preferred manufacturer rebate status, clean compliance record, and attractive lease in high-density market. |
Owner Dependency Risk
High Negative impactSingle-provider practices where all patient relationships rest on the selling audiologist face steep discounts. Buyers price in attrition risk, often demanding earnouts or extended seller transitions.
Patient Database Quality
High Positive impactA documented, active patient database with reappointment schedules and high average revenue per patient directly supports premium multiples from roll-up buyers and PE platforms.
Medicare & Insurance Compliance
High Negative / Positive impactClean billing records and no audit findings command buyer confidence. Prior Medicare irregularities or unresolved compliance issues can kill deals or trigger significant price reductions.
Manufacturer Relationships & Rebates
Moderate Positive impactPreferred provider agreements with top-tier hearing aid brands and favorable rebate structures improve margins and signal operational maturity, enhancing perceived earnings quality.
Revenue Diversification
Moderate Positive impactCenters balancing hearing aid sales, audiological testing, repairs, and insurance reimbursements show more resilient EBITDA, reducing buyer risk versus single-revenue-stream practices.
PE-backed audiology roll-ups remain aggressive acquirers in 2024, compressing cap rates for platform-ready practices. OTC hearing aid competition has increased scrutiny on sustainable revenue mix. Buyers now heavily weight associate audiologist depth and patient retention data during due diligence as valuation anchors.
Two-provider suburban hearing center with strong Medicare patient base, clean compliance record, and preferred manufacturer agreement in Southeast market.
$620K
EBITDA
4.8x
Multiple
$2.98M
Price
Owner-operated single-location clinic, retiring audiologist, solid patient database but no associate staff; earnout structured around 18-month transition.
$380K
EBITDA
3.75x
Multiple
$1.43M
Price
Growth-stage audiology group with two locations, associate audiologist, diversified revenue, acquired by regional ENT physician group as ancillary expansion.
$1.1M
EBITDA
5.6x
Multiple
$6.16M
Price
EBITDA Valuation Estimator
Get your Hearing Center business value range instantly
Industry: Hearing Center · Multiples based on 4.0x–4.75x (Established Independent)
Powered by Deal Flow OS
dealflow-os.com · Free M&A tools for every stage of the deal
Most independent hearing centers sell at 3.5x–6x EBITDA. Your specific multiple depends on associate staffing, patient retention, compliance record, and whether a roll-up platform is competing to acquire.
Yes. PE-backed audiology roll-ups often pay 5x–6x+ for platform-ready practices, while individual buyers typically pay 3.5x–4.5x, especially for owner-operated clinics requiring operational transition support.
Significantly. Clean billing records and no audit history support full valuation. Unresolved Medicare compliance issues are deal-breakers or trigger escrow holdbacks and substantial price reductions during due diligence.
Yes. Hearing centers are SBA 7(a) eligible. Most deals are structured with 10–20% buyer equity, SBA financing covering the bulk, and a seller note bridging any gap between loan limits and purchase price.
More Hearing Center Guides
DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers